143 related articles for article (PubMed ID: 12675719)
1. GUTI: a new antigen in the Cromer blood group system.
Storry JR; Sausais L; Hue-Roye K; Mudiwa F; Ferrer Z; Blajchman MA; Lublin DM; Ma BW; Miquel JF; Nervi F; Pereira J; Reid ME
Transfusion; 2003 Mar; 43(3):340-4. PubMed ID: 12675719
[TBL] [Abstract][Full Text] [Related]
2. SERF: a new antigen in the Cromer blood group system.
Banks J; Poole J; Ahrens N; Seltsam A; Salama A; Hue-Roye K; Storry JR; Palacajornsuk P; Ma BW; Lublin DM; Reid ME
Transfus Med; 2004 Aug; 14(4):313-8. PubMed ID: 15285728
[TBL] [Abstract][Full Text] [Related]
3. Three new high-prevalence antigens in the Cromer blood group system.
Hue-Roye K; Lomas-Francis C; Belaygorod L; Lublin DM; Barnes J; Chung A; Fung-Kee-Fung K; Kinney J; Goldman-Lavi R; Yahalom V; Poole J; Ivankovic Z; Alcantara D; Bekavac M; Cepulic BG; Velliquette RW; Mason R; Reid ME
Transfusion; 2007 Sep; 47(9):1621-9. PubMed ID: 17725726
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of Cromer blood group antigens.
Lublin DM; Kompelli S; Storry JR; Reid ME
Transfusion; 2000 Feb; 40(2):208-13. PubMed ID: 10686005
[TBL] [Abstract][Full Text] [Related]
5. Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor.
Daniels GL; Green CA; Powell RM; Ward T
Transfusion; 1998 Apr; 38(4):332-6. PubMed ID: 9595014
[TBL] [Abstract][Full Text] [Related]
6. Novel molecular basis of an Inab phenotype.
Hue-Roye K; Powell VI; Patel G; Lane D; Maguire M; Chung A; Reid ME
Immunohematology; 2005; 21(2):53-5. PubMed ID: 15954804
[TBL] [Abstract][Full Text] [Related]
7. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy.
Reid ME; Chandrasekaran V; Sausais L; Pierre J; Bullock R
Vox Sang; 1996; 71(1):48-50. PubMed ID: 8837357
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.
Lublin DM; Mallinson G; Poole J; Reid ME; Thompson ES; Ferdman BR; Telen MJ; Anstee DJ; Tanner MJ
Blood; 1994 Aug; 84(4):1276-82. PubMed ID: 7519480
[TBL] [Abstract][Full Text] [Related]
9. Decay-accelerating factor (CD55) deficiency phenotypes in Japanese.
Daniels GL; Green CA; Mallinson G; Okubo Y; Hori Y; Kataoka A; Kaihara M
Transfus Med; 1998 Jun; 8(2):141-7. PubMed ID: 9675792
[TBL] [Abstract][Full Text] [Related]
10. Analysis of SERF in Thai blood donors.
Palacajornsuk P; Hue-Roye K; Nathalang O; Tantimavanich S; Bejrachandra S; Reid ME
Immunohematology; 2005; 21(2):66-9. PubMed ID: 15954807
[TBL] [Abstract][Full Text] [Related]
11. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.
Telen MJ; Rao N; Udani M; Thompson ES; Kaufman RM; Lublin DM
Blood; 1994 Nov; 84(9):3205-11. PubMed ID: 7524769
[TBL] [Abstract][Full Text] [Related]
12. Novel single-nucleotide change in GYP*A in a person who made an alloantibody to a new high-prevalence MNS antigen called ENEV.
Velliquette RW; Hu Z; Lomas-Francis C; Hue-Roye K; Allen JL; Mirabella D; Reid ME
Transfusion; 2010 Apr; 50(4):856-60. PubMed ID: 20003059
[TBL] [Abstract][Full Text] [Related]
13. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.
Telen MJ; Hall SE; Green AM; Moulds JJ; Rosse WF
J Exp Med; 1988 Jun; 167(6):1993-8. PubMed ID: 2455016
[TBL] [Abstract][Full Text] [Related]
14. 3D analysis of CROMER (DAF) and a new antigen CRAG.
Floch A; Vege S; Hue-Roye K; Hamilton JR; Williams LA; Choate J; Lomas-Francis C; Westhoff CM
Blood Transfus; 2022 Nov; 20(6):483-488. PubMed ID: 35175190
[TBL] [Abstract][Full Text] [Related]
15. The Cromer blood group system: a review.
Storry JR; Reid ME; Yazer MH
Immunohematology; 2010; 26(3):109-18. PubMed ID: 21214297
[TBL] [Abstract][Full Text] [Related]
16. Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC.
Matthes T; Tullen E; Poole J; Banks J; Nagy M; Stelling MJ; Boehlen F; Michel M; Beris P; Hustinx H; Crew V; Daniels G
Transfusion; 2002 Nov; 42(11):1448-57. PubMed ID: 12421218
[TBL] [Abstract][Full Text] [Related]
17. Cromer-related antigens--blood group determinants on decay-accelerating factor.
Daniels G
Vox Sang; 1989; 56(4):205-11. PubMed ID: 2474898
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype.
Wang L; Uchikawa M; Tsuneyama H; Tokunaga K; Tadokoro K; Juji T
Blood; 1998 Jan; 91(2):680-4. PubMed ID: 9427725
[TBL] [Abstract][Full Text] [Related]
19. Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency).
Reid ME; Mallinson G; Sim RB; Poole J; Pausch V; Merry AH; Liew YW; Tanner MJ
Blood; 1991 Dec; 78(12):3291-7. PubMed ID: 1720702
[TBL] [Abstract][Full Text] [Related]
20. The Cromer blood group system: a review.
Storry JR; Reid ME
Immunohematology; 2002; 18(4):95-103. PubMed ID: 15373545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
